Glucose Targets for Gestational Diabetes Mellitus (GDM)
The recommended glucose targets for gestational diabetes mellitus (GDM) are fasting plasma glucose <95 mg/dL (5.3 mmol/L) and either 1-hour postprandial <140 mg/dL (7.8 mmol/L) or 2-hour postprandial <120 mg/dL (6.7 mmol/L). 1, 2, 3
Target Glucose Values for GDM
- Fasting plasma glucose target: <95 mg/dL (5.3 mmol/L) 1, 2
- 1-hour postprandial target: <140 mg/dL (7.8 mmol/L) 1, 2
- 2-hour postprandial target: <120 mg/dL (6.7 mmol/L) 1, 2
These targets are based on recommendations from the Fifth International Workshop-Conference on Gestational Diabetes Mellitus and have been consistently endorsed by the American Diabetes Association across multiple guidelines 1.
Monitoring Recommendations
- Both fasting and postprandial monitoring are essential for optimal glucose control in GDM 1, 2
- Postprandial hyperglycemia is a primary driver of macrosomia and other adverse fetal outcomes in GDM 2
- The timing of peak postprandial glucose excursions varies between patients (range 45-120 minutes after meals) 2
- Postprandial measurements should be taken 1-2 hours after beginning the meal 2
- The choice between 1-hour vs. 2-hour postprandial monitoring can be based on clinical context, with evidence suggesting similar outcomes with either approach 4
HbA1c Targets in Pregnancy
- An HbA1c target of <6% (<42 mmol/mol) is optimal if achievable without significant hypoglycemia 1, 3
- HbA1c should be monitored more frequently during pregnancy (e.g., monthly) due to altered red blood cell kinetics 1, 3
- HbA1c should not replace blood glucose monitoring as it may not adequately detect postprandial hyperglycemia 1
Special Considerations for Pre-existing Diabetes in Pregnancy
For women with pre-existing type 1 or type 2 diabetes who become pregnant, stricter targets are recommended 1, 3:
- Premeal, bedtime, and overnight glucose: 60–99 mg/dL (3.3–5.4 mmol/L) 1
- Peak postprandial glucose: 100–129 mg/dL (5.4–7.1 mmol/L) 1, 3
- A1C <6.0% 1
Management Approach
- Lifestyle modification is the first-line treatment for GDM 1, 2
- Medical nutrition therapy should be individualized with guidance from a registered dietitian 1, 3
- Physical activity of moderate intensity is recommended if not contraindicated 5, 6
- If glucose targets cannot be achieved with lifestyle modifications, insulin therapy should be initiated as the first-choice medication 1, 5
- 70-85% of women diagnosed with GDM under Carpenter-Coustan criteria can achieve adequate control with lifestyle modification alone 1, 7
Pitfalls to Avoid
- Avoid relying solely on HbA1c for monitoring due to altered red blood cell turnover during pregnancy 1, 2
- Be cautious about nocturnal hypoglycemia in patients with tight glucose control 2
- Avoid excessive carbohydrate restriction that could lead to ketosis 2
- Do not base clinical decisions solely on maternal glucose values without considering fetal status 7
- Be aware that insulin requirements typically level off toward the end of the third trimester, and a rapid reduction may indicate placental insufficiency 7
Long-term Follow-up
- All women with GDM should be tested for persistent diabetes or prediabetes at 4-12 weeks postpartum using a 75g OGTT 1, 5
- Lifelong screening for diabetes should be performed at least every 2-3 years using standard non-pregnant criteria 1, 5
- Women should be informed about their increased risk of developing type 2 diabetes and cardiovascular disease at follow-up 5, 6